Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FDQZW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,415
Award facts
- Contract value 100% obligated
- $10,414.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,414.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The award, issued on August 28, 2025, with an ultimate completion date of September 19, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA under the SPE2DB program, a $499,999,999 blanket purchasing agreement valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering prescription medications, biologics, and medical consumables to Department of Defense healthcare sites across the nation. The company's contract portfolio demonstrates expertise in supplying diverse pharmaceutical products ranging from contraceptive devices and oncology treatments to vaccines and specialty medications. This particular delivery order for Nexplanon implants—a subdermal contraceptive device—reflects the company's ongoing role in supporting the medical supply requirements of military healthcare systems through the DLA's pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DB25FDQZW?
SPE2DB25FDQZW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FDQZW worth?
The government has obligated $10,415 on SPE2DB25FDQZW.
Is contract SPE2DB25FDQZW an order under another contract?
Yes. SPE2DB25FDQZW is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDQZW competed?
The extent of competition for SPE2DB25FDQZW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award